Chemo-Radiation Therapy
Showing 1 - 25 of >10,000
Glioblastoma Trial in Pittsburgh (Radiation Therapy, Temozolomide Oral Product)
Recruiting
- Glioblastoma
- Radiation Therapy
- Temozolomide Oral Product
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center, Radiation Oncology
Jan 6, 2022
Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum Trial in Assiut (short course chemo-radiation
Recruiting
- Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum
- short course chemo-radiation with 5-fluorouracil
-
Assiut, Assuit, EgyptAssiut University
Feb 14, 2022
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes
Recruiting
- Unresectable /Inoperable Locally Advanced (Stage II-III) Non-small Cells Lung Cancer (NSCLC)
-
Grozny, Russian Federation
- +4 more
May 31, 2023
Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),
Recruiting
- Oropharynx Cancer
- Radiation therapy (5 days for 7 weeks)
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Apr 5, 2023
Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)
Active, not recruiting
- Lung Cancer, Non-small Cell
- hypofractionated radiation therapy
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Mar 13, 2023
Head Neck Cancer, Larynx Trial in Lexington (Low dose fractionated radiation - 80cGy with chemo, Docetaxel and Carboplatin AUC
Active, not recruiting
- Head and Neck Cancer
- Larynx
- Low dose fractionated radiation - 80cGy with chemotherapy
- Docetaxel and Carboplatin AUC 6
-
Lexington, KentuckyUniversity of Kentucky, Markey Cancer Center
Aug 29, 2022
or Chemoradiotherapy Patient Care in Oropharyngeal Cancer
Recruiting
- Oropharyngeal Carcinoma
- Electronic Health Record Review
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)
Completed
- Squamous Cell Carcinoma of Head and Neck
- sEphB4-HSA with chemotherapy
- +2 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 9, 2022
Head-and-neck Squamous Cell Carcinoma Trial in Germany (De-escalation radio(chemo)therapy - Level 1, De-escalation
Recruiting
- Head-and-neck Squamous Cell Carcinoma
- De-escalation radio(chemo)therapy - Level 1
- +2 more
-
Freiburg, Baden-Wuerttemberg, Germany
- +9 more
Aug 2, 2022
Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,
Recruiting
- Gastric Adenocarcinoma
- +4 more
- Capecitabine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2022
Non-Small Cell Lung Cancer and Esophageal Cancer Treated With
Completed
- Lung Cancer
- Esophageal Cancer
- Carboplatin
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Oct 11, 2021
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,
Withdrawn
- Triple Negative Breast Cancer
- +4 more
- Nab-paclitaxel
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 2, 2022
Tumors Trial in Schweinfurt (MyAmino, betaquik, Radio(chemo)therapy)
Completed
- Neoplasms
- MyAmino
- +2 more
-
Schweinfurt, Bavaria, GermanyDepartment of Radiotherapy and Radiation Oncology
Oct 17, 2022
Rectal Cancer Trial in New Haven (Chemo with concomitant Capecitabine and KD018)
Completed
- Rectal Cancer
- Chemo with concomitant Capecitabine and KD018
-
New Haven, ConnecticutYale Cancer Center
Oct 2, 2020
Cervical Cancer Trial in Prague (No adjuvant therapy, Adjuvant radiotherapy)
Recruiting
- Cervical Cancer
- No adjuvant therapy
- Adjuvant radiotherapy
-
Prague, CzechiaGeneral University Hospital in Prague
Jul 25, 2022
Cervical Cancer, Advanced Cancer Trial in Romania, Spain, Turkey (No Further Treatment, TSR-042)
Recruiting
- Cervical Cancer
- Advanced Cancer
- No Further Treatment
- TSR-042
-
Elche, Alicante, Spain
- +28 more
Oct 17, 2022
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (Stereotactic Ablative Radiotherapy, Resection,
Not yet recruiting
- Metastatic Colorectal Adenocarcinoma
- Stage IV Colorectal Cancer AJCC v8
- Stereotactic Ablative Radiotherapy
- +6 more
- (no location specified)
Dec 21, 2022
Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)
Recruiting
- Small-cell Lung Cancer
- Carboplatin
- +3 more
-
New York, New YorkColumbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022
Merkel Cell Carcinoma Trial in Australia (Carboplatin, Etoposide, Radiotherapy)
Completed
- Merkel Cell Carcinoma
- Carboplatin
- +2 more
-
Campbelltown, New South Wales, Australia
- +12 more
Nov 17, 2022
Non-metastatic, Non-recurrent Lung and Esophageal Cancer
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +55 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 5, 2023
Colorectal Tumors Trial in São Paulo (Folfirinox)
Recruiting
- Colorectal Neoplasms
-
São Paulo, BrazilHospital Municipal Vila Santa Catarina
Oct 5, 2021
Radiotherapy; Complications, Head Neck Cancer Trial in Moscow (Oral nutritional supplements (ONS) with a cooling effect + ONS
Recruiting
- Radiotherapy; Complications
- Head and Neck Cancer
- Oral nutritional supplements (ONS) with a cooling effect + ONS without a sensor component and taste + standard diet
- +2 more
-
Moscow, Russian FederationP. Hertsen Moscow Oncology Research Institute
Apr 8, 2022
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- +2 more
- Carboplatin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Rates to Radiation Alone or With Chemo In Head & Neck Cancer
Completed
- Larynx Cancer
- +4 more
-
Lexington, KentuckyMarkey Cancer Center
Jul 12, 2021
CMV Infections in Brain Tumors or Brain Metastases During and
Recruiting
- Cytomegalovirus Infections
- Blood draw and MRI
-
Erlangen, Bavaria, GermanyDepartement of Radiation Oncology, Universitätsklinikum Erlangen
Apr 26, 2021